Skip to main content
Clinical Trials/NCT04121754
NCT04121754
Completed
N/A

Post-Stroke Walking Speed and Community Ambulation Conversion, A Pivotal Study

MedRhythms, Inc.8 sites in 1 country87 target enrollmentSeptember 17, 2019
ConditionsChronic Stroke

Overview

Phase
N/A
Intervention
Not specified
Conditions
Chronic Stroke
Sponsor
MedRhythms, Inc.
Enrollment
87
Locations
8
Primary Endpoint
Mean Change in Gait Speed measured by the 10-Meter Walk Test
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this randomized, controlled study is to collect performance data on the ability of an investigational device designed to digitally deliver Rhythmic Auditory Stimulation to improve walking speed in people who suffered a stroke greater than six (6) months in the past and who are limited in mobility outside the home. The primary outcomes will be the mean change in walking speed (meters per second) and mean percent change in walking speed as determined by a 10-meter Walk Test after five weeks of intervention and compared between groups.

Detailed Description

Study participants who take part in this research study will participate in a screening visit, fifteen (15) intervention visits over approximately five weeks and a final closing visit. Study participants will be assigned by chance to one of the two study groups. Participants will not be able to switch groups once they are assigned. The investigational device includes a mobile device app and sensors that are attached to shoes. Headphones and a mobile device are also required to be used and will be provided in this study.

Registry
clinicaltrials.gov
Start Date
September 17, 2019
End Date
February 11, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 50 years of age and older
  • Equal to or greater than six months post-stroke
  • A comfortable walking speed greater or equal to 0.5 meters per second (m/s), but less than 0.8m/s, as determined by a 10-meter walk test.
  • Demonstrates some level of asymmetry in gait

Exclusion Criteria

  • Has a known history of neurologic (excluding stroke) injury
  • Has had more than 2 falls in the previous month
  • Is enrolled in another walking rehabilitation intervention (e.g., physical therapy)
  • Has an external lower limb prosthetic ("artificial limb")
  • Has a hearing impairment
  • Had orthopedic surgery in the last year
  • Has severe aphasia and/or a speech/language disorder
  • Has co-morbidities that prevent participation in exercise

Outcomes

Primary Outcomes

Mean Change in Gait Speed measured by the 10-Meter Walk Test

Time Frame: Baseline through study completion, an average of six weeks

Mean change in gait speed (meters per second) measured by the 10-Meter Walk Test compared between groups.

Mean Percent Change in Gait Speed measured by the 10-Meter Walk Test

Time Frame: Baseline through study completion, an average of six weeks

Mean percent change in gait speed (meters per second) measured by the 10-Meter Walk Test compared between groups.

Secondary Outcomes

  • Community Ambulation Status measured by the 10-Meter Walk Test(At study completion, an average of six weeks)
  • Change in Stride Length (meters) as measured by a validated, instrumented walkway system(Baseline through study completion, an average of six weeks)
  • Change in Cadence (steps per minute) as measured by a validated, instrumented walkway system(Baseline through study completion, an average of six weeks)
  • Change in self-perceived disability as measured by the Stroke Impact Scale (SIS), Version 3.0(Baseline through study completion, an average of six weeks)
  • Change in Temporal Symmetry (percent) as measured by a validated, instrumented walkway system(Baseline through study completion, an average of six weeks)
  • Change in Spatial Symmetry (percent) as measured by a validated, instrumented walkway system(Baseline through study completion, an average of six weeks)
  • Change in Quality of Life as measured by the Stroke-Specific Quality of Life Scale (SS-QOL)(Baseline through study completion, an average of six weeks)

Study Sites (8)

Loading locations...

Similar Trials